RituximabPneumonia following off label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1779卷 / 1期

关键词：

D O I：

10.1007/s40278-019-71471-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：207 / 207

相关论文

共 50 条

[21] FluoxetineAkathisia following off label use: case report
Reactions Weekly, 2020, 1811 (1) : 130 - 130
[22] KetamineHypertension following off label use: case report
Reactions Weekly, 2020, 1818 (1) : 160 - 160
[23] OsimertinibPneumonitis following off label use: case report
Reactions Weekly, 2021, 1867 (1) : 340 - 340
[24] AntineoplasticsMyelosuppression following off label use: case report
Reactions Weekly, 2021, 1844 (1) : 46 - 46
[25] AripiprazoleHypothermia following off label use: case report
Reactions Weekly, 2022, 1930 (1) : 91 - 91
[26] RituximabHypotension following off label use: case report
Reactions Weekly, 2018, 1703 (1) : 236 - 236
[27] MethylphenidatePriapism following off label use: case report
Reactions Weekly, 2017, 1636 (1) : 214 - 214
[28] BevacizumabEndophthalmitis following an off label use: case report
Reactions Weekly, 2017, 1680 (1) : 69 - 69
[29] AntipsychoticsVarious toxicities following off label use: case report
Reactions Weekly, 2020, 1811 (1) : 48 - 48
[30] DexamethasoneHyperglycaemia following off-label use: case report
Reactions Weekly, 2022, 1896 (1) : 173 - 173

← 1 2 3 4 5 →